Is the Best Plate a Nail? A Review of 3230 Unstable Intertrochanteric Fractures of the Proximal Femur
| Autor: | Sinead McDonald, Adam Tucker, Kevin J. Donnelly, Andrew P. Foster, Clare Rowan |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
musculoskeletal diseases Bone Screws Dentistry Bone Nails Prosthesis Implantation 03 medical and health sciences 0302 clinical medicine medicine Humans Orthopedics and Sports Medicine 030212 general & internal medicine Aged Aged 80 and over 030222 orthopedics Proximal femur Hip Fractures business.industry Recovery of Function General Medicine musculoskeletal system medicine.anatomical_structure Nail (anatomy) Female Surgery business Bone Plates |
| Zdroj: | Journal of Orthopaedic Trauma. 32:53-60 |
| ISSN: | 0890-5339 |
| DOI: | 10.1097/bot.0000000000001038 |
| Popis: | To evaluate the functional outcomes, revision, and mortality rates of 3 implants used for unstable intertrochanteric hip fractures; the sliding hip screw (SHS), with or without a trochanteric stabilization plate (TSP); and a cephalomedullary nail (CMN).Multicentre National Prospective Cohort Study.Northern Ireland.Patients were identified from a prospective database. Fractures were classified according to OTA/AO A31A2.2, A2.3, and A3. All patients had a minimum of 12 months of follow-up.Patients received either an SHS, an SHS in combination with a TSP, or a CMN. Implant choice was at the discretion of the operating surgeon.Primary outcome was 12-month mortality analyzed by the Kaplan-Meier survival analysis. Secondary outcomes included 12-month functional status using a validated score and all time revision of implants for any reason.In total, 3230 patients met the inclusion criteria (2474 SHS, 158 SHS + TSP, and 598 CMN). CMN use increased over time, with concomitant reduction in SHS use. There was no significant difference in functional outcomes at 12 months (analysis of variance, P = 0.177). Although men were significantly younger, they were at a higher risk of 12-month mortality. CMNs had statistically significantly lower 12-month mortality rates (P = 0.0148). The highest revision rate (4.04%) was seen in patients treated with SHS alone (P = 0.041).The use of a CMN in unstable intertrochanteric hip fractures conveys the best results in functional outcomes, 12-month mortality, and has lower revision rates compared with an SHS ± TSP.Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|